uniQure to Participate in Multiple Upcoming Industry Conferences in December
December 02, 2019 07:00 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Dec. 02, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Equillium to Present Translational Data on Itolizumab for Acute Graft-Versus-Host Disease at 61st American Society of Hematology (ASH) Annual Meeting and Exposition
November 26, 2019 16:07 ET
|
Equillium
LA JOLLA, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat...
uniQure Announces Clinical Data Presentations at the 61st American Society of Hematology (ASH) Annual Meeting
November 06, 2019 09:16 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 06, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Aprea Therapeutics to Present Data from U.S. Phase 1b/2 MDS/AML Trial and French Phase 1b/2 MDS/AML Trial at 61st American Society of Hematology Annual Meeting
November 06, 2019 09:15 ET
|
Aprea Therapeutics
BOSTON, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate...
Constellation Pharmaceuticals Announces MANIFEST Data Updates Will Be Provided in Oral and Poster Sessions on December 9 at ASH
October 10, 2019 07:00 ET
|
Constellation Pharmaceuticals , Inc.
Company will hold investor event on December 9 at 12:30 PM CAMBRIDGE, Mass., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical...
Notable Labs Collaborator at ASH Shows Company’s Platform Predicts Ex Vivo Drug Response in Myeloid Neoplasms
December 03, 2018 22:43 ET
|
Notable Labs, Inc.
SAN DIEGO and FOSTER CITY, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Notable Labs, Inc., a mission-driven company aiming to transform the way cancer is treated, announced today that the Company and...
OHSU and Aptose Present New CG-806 Preclinical Data at ASH 60th Annual Meeting
December 03, 2018 07:10 ET
|
Aptose Biosciences, Inc.
PORTLAND, Ore. and SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Oregon Health & Science University (OHSU) and Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) today announced the presentation of...
Aptose Presents New Preclinical Data on CG-806 PAN-FLT3/PAN-BTK Inhibitor at ASH 60th Annual Meeting
December 03, 2018 07:05 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) today announced the presentation of preclinical data from research led by The University of...
NanoString Technologies Highlights Advances in Precision Oncology at the 60th Annual Meeting of the American Society of Hematology
November 29, 2018 06:00 ET
|
NanoString Technologies, Inc.
SEATTLE, Nov. 29, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced...
Incysus Therapeutics Announces Presentations at 2018 ASH and HAPLO Annual Meetings
November 28, 2018 16:00 ET
|
Incysus Therapeutics, Inc.
NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...